Search Our Website:
Sep 28 2023

Linda Pissott Reig, shareholder in the firm’s FDA/Biotech and Life Sciences practice groups, organized a recent BioNJ Legal, Compliance & Regulatory Advisory Group Discussion on September 28 entitled, Trends in Alliances, Collaborations & Other Partnership Arrangements: US & Global Marketplace Challenges and Opportunities from a Business Development Perspective. Ms. Reig co-moderated the program, along with Mark Gaydos, Head of Global Regulatory Affairs, Advertising, Promotion and Labeling at Sanofi.

Panelists Somjeet Dey, Director, Business Development, Otsuka America Pharmaceutical, Inc. and Keriann Masters, Senior Director, Corporate Counsel, Otsuka America Pharmaceutical, Inc. discussed the opportunities and challenges related to business development within the life sciences industry.